Akirov Amit, Diker-Cohen Talia, Masri-Iraqi Hiba, Shimon Ilan
Institute of Endocrinology, Beilinson Hospital, 4941492 Petach Tikva, Israel.
Sackler School of Medicine, Tel Aviv University, 6997801 Tel Aviv, Israel.
J Clin Endocrinol Metab. 2017 Jul 1;102(7):2230-2241. doi: 10.1210/jc.2017-00450.
Glucose variability (GV) is common among hospitalized patients, but the prognostic implications are not understood.
Investigate the association between GV, hospital length of stay (LOS), and mortality.
GV was assessed by coefficient of variance (CV) and standard deviation (SD) of glucose values during hospitalization.
Historical prospectively collected data of patients hospitalized between January 2011 and December 2013.
Patients ≥18 years old.
LOS, and in-hospital and mortality at end of follow-up.
The cohort included 20,303 patients (mean age ± SD, 70 ± 17 years; 51% men; median follow-up, 1022 days), of whom 8565 patients (42%) had diabetes mellitus (DM). Mean LOS was longer with higher CV or SD tertiles in patients without and with DM. In-hospital mortality was 8.2%, associated with higher tertiles of CV (4%, 10%, 19%) and SD (4%, 11%, 21%) in patients without DM and with DM (3%, 5%, 10%; and 2%, 4%, 9%, respectively). Mortality at the end of follow-up was increased in patients without DM with higher CV (28%, 42%, 55%) and SD (28%, 44%, 57%) tertiles and in patients with DM (26%, 35%, 45%; and 25%, 34%, 44%, respectively). Multivariate analysis indicated increased risk for in-hospital and end of follow-up mortality, in both groups. Adjustment for glucocorticoid treatment or hypoglycemia did not affect the results. Glucose levels during hospitalization and GV were two independent factors affecting LOS and in-hospital mortality. In each CV tertile, mortality was higher with median glucose ≥180 mg/dL, compared with <180 mg/dL.
In hospitalized patients with and without DM, increased GV is associated with longer hospitalization and increased short- and long-term mortality.
血糖变异性(GV)在住院患者中很常见,但对其预后影响尚不清楚。
研究GV、住院时间(LOS)和死亡率之间的关联。
通过住院期间血糖值的变异系数(CV)和标准差(SD)评估GV。
前瞻性收集2011年1月至2013年12月期间住院患者的历史数据。
年龄≥18岁的患者。
LOS、随访结束时的院内死亡率和总体死亡率。
该队列包括20303例患者(平均年龄±标准差,70±17岁;51%为男性;中位随访时间为1022天),其中8565例患者(42%)患有糖尿病(DM)。无论有无DM,CV或SD三分位数越高,平均住院时间越长。院内死亡率为8.2%,无DM患者和有DM患者的CV(4%、10%、19%)和SD(4%、11%、21%)三分位数越高,死亡率越高(无DM患者和有DM患者分别为3%、5%、10%;2%、4%、9%)。随访结束时,无DM患者CV(28%、42%、55%)和SD(28%、44%、57%)三分位数越高,死亡率增加,有DM患者(分别为26%、35%、45%;25%、34%、44%)死亡率也增加。多因素分析表明,两组患者院内和随访结束时的死亡风险均增加。调整糖皮质激素治疗或低血糖情况不影响结果。住院期间的血糖水平和GV是影响LOS和院内死亡率的两个独立因素。在每个CV三分位数中,中位血糖≥180mg/dL的患者死亡率高于<180mg/dL的患者。
在有或无DM的住院患者中,GV增加与住院时间延长以及短期和长期死亡率增加相关。